CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days
The Indian Hotels Company Ltd. 24/08/2023401.85517.9007/02/2024 28.88% 167 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

IT penny stock under Rs 35 in green after securing Make-In-India AI-based healthcare solution contract from a prominent Us based client
Kiran Shroff
/ Categories: Trending, Penny Stocks

IT penny stock under Rs 35 in green after securing Make-In-India AI-based healthcare solution contract from a prominent Us based client

The stock is up by 38 per cent from its 52-week low of Rs 23.04 per share.

On Thursday, the shares of Blue Cloud Softech Solutions Ltd gained 4.33 per cent to Rs 31.83 per share from its previous closing of Rs 30.51 per share. The stock’s 52-week high is Rs 130.50 and its 52-week low is Rs 23.04.

Blue Cloud Softech Solutions Limited (BCSSL) has achieved a significant milestone by securing a USD 3.20 million contract with a US-based client for its "Make-in-India" AI-based healthcare solution, the BluHealth Comprehensive Healthcare Platform. This deal, announced today, highlights BCSSL's growing global presence and its ability to deliver advanced, client-focused technology. The platform, designed to revolutionize primary healthcare, features two key components: BluHealth-Screener for integrated record management and analytics, and BluHealth-Scanner for real-time health parameter assessments. This contract reinforces BCSSL's position as a leader in innovative technology solutions.

The BluHealth platform's core strength lies in its ability to connect with citizen charter platforms, fostering transparency and providing real-time operational intelligence. By utilizing AI-driven insights, the platform enables organizations to effectively monitor and optimize their healthcare schemes, ensuring measurable and timely outcomes for citizens. This technology empowers healthcare providers to deliver more efficient and targeted services, ultimately improving the overall quality of care. This substantial contract not only validates the effectiveness of BCSSL's solutions but also underscores the potential of Indian-developed AI technology in the global healthcare market.

Earlier, shares of Blue Cloud Softech Solutions Limited ex-traded stock split in the ratio 2:1 i.e., sub-division of equity shares of the company having a Face Value of Rs 2 each (fully paid-up) into one equity share of face value of Re 1 each (fully paid-up). The record date for the stock split was Monday, January 20, 2025.

DSIJ’s 'Tiny Treasure' service recommends researched Small-Cap stocks with Inherent Growth Potential. If this interests you, do download the service details here.

About the Company

Headquartered in Hyderabad, Telangana, Blue Cloud Softech Solutions Limited (BCSSL) is a pioneering provider of AIoT-based solutions specializing in AI-driven healthcare and technology products. With a steadfast commitment to innovation, BCSSL empowers businesses and communities alike by delivering cutting-edge, indigenous technology solutions that drive measurable transformation.

According to Quarterly Results, the company reported net sales of Rs 235.27 crore in Q3FY25 and net profit increased by 131 per cent to Rs 9.40 crore in Q3FY25 compared to Q3FY24. In its nine-month results, the net sales increased by 112 per cent to Rs 613.24 crore and net profit increased by 316 per cent to Rs 31.23 crore in 9MFY25 compared to 9MFY24.  

The company has a market cap of Rs 1,350 crore with a 3-year stock price CAGR of 60 per cent. The stock is up by 38 per cent from its 52-week low of Rs 23.04 per share. Investors should keep an eye on this small-cap IT stock.

Disclaimer: The article is for informational purposes only and not investment advice. 

Previous Article Midcap & Smallcap Indices Down Upto 1.8 Per Cent! Sensex Trades Flat
Next Article Shares Below Rs 100: Only Buyers Were Seen In These Stocks, Locked in Upper Circuit Today
Print
314 Rate this article:
3.8
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR